Covid-19 has devastated communities and overwhelmed treatment facilities across the globe since the early months of 2020. At the outset, little was known about the pattern of symptoms associated with Covid-19 infection, as the symptoms were non-specific and varied among patients.
As data has been collected and studied, however, the complicating medical conditions, or comorbidities, associated with Covid-19 have become better understood. The most severe comorbidities are pneumonia, acute respiratory distress syndrome (ARDS), myocardial infarction (MI), and sepsis. There are no reliable biomarkers for ARDS, but biomarkers are in routine clinical use for the other comorbidities.
Scripps offers several excellent antigens and antibodies, specific for the biomarkers associated with pneumonia, MI, and sepsis. These reagents are available now to further your research and development efforts in assisting with the risk stratification of Covid-19 patients.
CLICK HERE to learn more and purchase your Biomarkers today!